Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs
Geriatrics & Gerontology International · 2024-03 · 24 (S1) · 81-87
DOI: 10.1111/ggi.14706 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 23.10.2023. Verfasst von Shizuo Yamada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Older adults frequently have many systemic diseases that require treatment with multiple drugs, and thus anticholinergic adverse effect by polypharmacy is a significant concern in the management of older adults. The accuracy of the anticholinergic burden rating may be increased by considering pharmacokinetic and pharmacodynamic factors such as biophase drug concentrations, the pharmacologically active metabolites formed after drug administration, and muscarinic receptor‐mediated effects. Therefore, a pharmacological evidence‐based burden scale that considers pharmacokinetic and pharmacodynamic factors is expected to be a more optimal tool for precisely assessing the anticholinergic burden, specifically risk reductions in anticholinergic adverse events in the poly‐medicated elderly. Geriatr Gerontol Int 2024; 24: 81–87 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Japan.
ORCID-Profile: Shizuo Yamada, Yoshihisa Kato
Zitieren
APA
Yamada, S., Mochizuki, M., Atobe, K., & Kato, Y. (2024). Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs. Geriatrics & Gerontology International, 24(S1), 81-87. https://doi.org/10.1111/ggi.14706
Vancouver
Yamada S, Mochizuki M, Atobe K, Kato Y. Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs. Geriatrics & Gerontology International. 2024;24(S1):81-87. doi:10.1111/ggi.14706
BibTeX
@article{Yamada2024,
author = {Yamada, Shizuo and Mochizuki, Masae and Atobe, Kazutaka and Kato, Yoshihisa},
title = {Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs},
journal = {Geriatrics & Gerontology International},
year = {2024},
volume = {24},
number = {S1},
pages = {81--87},
doi = {10.1111/ggi.14706}
}
EUVIMED